We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Researchers develop gene remedy that may goal airway and lungs by way of nasal spray
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Researchers develop gene remedy that may goal airway and lungs by way of nasal spray
Researchers develop gene remedy that may goal airway and lungs by way of nasal spray
Health

Researchers develop gene remedy that may goal airway and lungs by way of nasal spray

Last updated: May 23, 2025 6:21 am
Editorial Board Published May 23, 2025
Share
SHARE

Graphical summary. Credit score: Cell Stories Drugs (2025). DOI: 10.1016/j.xcrm.2025.102144

For gene remedy to work effectively, therapeutic molecules should be effectively delivered to the proper areas within the physique—a job generally given to adeno-associated viruses (AAV).

To enhance the AAV’s skill to ship therapeutics particularly to the lungs and airway, Mass Common Brigham researchers developed and utilized a brand new model, referred to as AAV.CPP.16, that may be administered with a nasal spray. In preclinical fashions, the modern device outperformed earlier variations by extra successfully focusing on the airway and lungs and exhibiting promise for respiratory and lung gene remedy. Outcomes are revealed in Cell Stories Drugs.

“We noticed that AAV.CPP.16, which we initially engineered to enter the central nervous system, also efficiently targeted lung cells,” stated senior writer FengFeng Bei, Ph.D., of the Division of Neurosurgery at Brigham and Girls’s Hospital. “This prompted us to further investigate AAV.CPP.16 for intranasal gene delivery to the respiratory airways.”

The researchers discovered AAV.CPP.16 outperformed earlier variations (AAV6 and AAV9) in cell tradition, mouse fashions, and non-human primate fashions. They then used the extra environment friendly device to ship scar-preventing gene remedy for pulmonary fibrosis, utilizing a mouse mannequin of the respiratory illness. Additionally they used the device to ship gene remedy for a viral an infection, the place the remedy prevented the replication of the SARS-CoV-2 virus in a mouse mannequin of COVID-19.

“Although further research is needed, our findings suggest that intranasal AAV.CPP.16 has strong translational potential as a promising delivery tool for targeting the airway and lung,” stated Bei.

Extra data:
Zhi Yang et al, Cross-species tropism of AAV.CPP.16 within the respiratory tract and its gene therapies in opposition to pulmonary fibrosis and viral an infection, Cell Stories Drugs (2025). DOI: 10.1016/j.xcrm.2025.102144

Supplied by
Mass Common Brigham

Quotation:
Researchers develop gene remedy that may goal airway and lungs by way of nasal spray (2025, Might 22)
retrieved 23 Might 2025
from https://medicalxpress.com/information/2025-05-gene-therapy-airway-lungs-nasal.html

This doc is topic to copyright. Aside from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for data functions solely.

You Might Also Like

AI measure of nearsightedness boosts eye illness prediction

AI-based device can ‘measure’ most cancers aggressiveness and paves the best way for brand spanking new therapies

Enhancing strategies for diagnosing esophageal problems

Excessive dietary inflammatory index tied to elevated prevalence of eczema

Medical tourism for bariatric/weight discount surgical procedure wants pressing regulation, say specialists

TAGGED:airwaydevelopgeneLungsnasalResearchersspraytargettherapy
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
How my grandmother’s harm confirmed me the best way to ‘All We Think about as Mild’
Entertainment

How my grandmother’s harm confirmed me the best way to ‘All We Think about as Mild’

Editorial Board January 7, 2025
Making ‘Aftershock,’ a Documentary About Black Maternal Mortality
Important Crawl House Upkeep: What You Have to Know
Antidepressant withdrawal signs extra frequent amongst long-term customers, research finds
Samsung unveils next-gen Odyssey gaming screens with immersive 3D and OLED

You Might Also Like

Examine finds stigma drives melancholy in alopecia sufferers, reasonably than sickness severity
Health

Examine finds stigma drives melancholy in alopecia sufferers, reasonably than sickness severity

July 16, 2025
The key sequence: How eye contact timing influences our social understanding
Health

The key sequence: How eye contact timing influences our social understanding

July 16, 2025
Analysis highlights unreliable responses from most Amazon MTurk customers, apart from ‘grasp’ employees
Health

Analysis highlights unreliable responses from most Amazon MTurk customers, apart from ‘grasp’ employees

July 15, 2025
Yoga, Tai Chi, strolling and jogging could also be greatest types of train for insomnia, knowledge counsel
Health

Yoga, Tai Chi, strolling and jogging could also be greatest types of train for insomnia, knowledge counsel

July 15, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • World
  • Art

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?